PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Jun-2023 Per Diem Nurse Staffing Market to Perceive Notable Growth of US$ 12.85 Billion by 2030 The Wire Times
01-Jun-2023 Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology Businesswire
01-Jun-2023 Paige Introduces New AI-Based Biomarker Screening Advancement to Drastically Reduce Diagnostic Turnaround Times and Inform Precision Treatment Decisions Businesswire
01-Jun-2023 Phase 3 Studies of Pfizer’s Novel Antibiotic Combination Offer New Treatment Hope for Patients with Multidrug-Resistant Infections and Limited Treatment Options Businesswire
01-Jun-2023 Ondine Biomedical Appoints Senior Pharma Executive Dr. Simon Sinclair as Chief Medical Officer Businesswire
01-Jun-2023 Pro-ficiency Launches Pf Library to Expand Study Training Service Suite Newswire
01-Jun-2023 PTP Announces Significant Investment by 424 Capital Businesswire
01-Jun-2023 Masimo Board of Directors Sets the Record Straight on False and Misleading Claims Businesswire
01-Jun-2023 Seven and Eight Biopharmaceuticals Announces Exclusive Clinical License Agreement with Eikon Therapeutics to Develop and Commercialize TLR7/8 dual agonists Businesswire
01-Jun-2023 Revvity’s EUROIMMUN Spearheads Cutting-Edge Diagnostic Analysis with New Automated IIFT System Businesswire
01-Jun-2023 Edge Group Global LLC Acquires Italian Soccer Team Casale Businesswire
01-Jun-2023 Portable Oxygen Concentrators Market Business Report 2023 is expected to Reach the Valuation of USD 3.03 billion by 2030 and at CAGR of 8.5% The Wire Times
01-Jun-2023 Venous Thromboembolism Market Would Rocket Up to at Value of USD 1824.57 million by 2029 The Wire Times
01-Jun-2023 Next Generation Sequencing (NGS) Market is Set to Exceed the Valuation of USD 29,307.13 million at a CAGR of 17.1% During the Forecast Period 2029 The Wire Times
01-Jun-2023 Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency Businesswire
01-Jun-2023 Vistagen Presents Fasedienol (PH94B) Safety and Exploratory Efficacy Data from Phase 3 Open-Label Social Anxiety Disorder Study at American Society for Clinical Psychopharmacology Annual Meeting Businesswire
01-Jun-2023 Eikon Therapeutics Builds Leading Clinical Development Organization with Appointment of Senior Team with Extensive Industry Expertise Businesswire
01-Jun-2023 Biomarker Analysis Publication Highlights Key Signals of Disability Worsening Associated With Neuromyelitis Optica Spectrum Disorder (NMOSD) Attacks, Illustrates Efficacy of UPLIZNA® (inebilizumab-cdon) Businesswire
01-Jun-2023 Massive Bio Launches Revolutionary ChatGPT-Powered Chatbot Platform at ASCO 2023 to Simplify and Expand Access to Oncology Clinical Trials Businesswire
01-Jun-2023 Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences Businesswire